| Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients (NCT02133885) | University of Florida | 2023-01-30 |
| Acetazolamide on REM OSA (NCT05589792) | Brigham and Women's Hospital | 2023-01-30 |
| Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1 (NCT04480554) | University of Pennsylvania | 2023-01-30 |
| Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer (NCT05617040) | Barinthus Biotherapeutics | 2023-01-30 |
| Study of ARO-MMP7 Inhalation Solution in Healthy Participants and Participants With Idiopathic Pulmonary Fibrosis (NCT05537025) | Arrowhead Pharmaceuticals | 2023-01-30 |
| Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid (NCT05703074) | University Hospital, Akershus | 2023-01-30 |
| A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma (NCT05712083) | Zhejiang University | 2023-01-30 |
| Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome (NCT05843968) | Children's Hospital of Chongqing Medical University | 2023-01-29 |
| A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer (NCT05609370) | BeiGene | 2023-01-29 |
| Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection (NCT05741099) | Hebei Medical University | 2023-01-28 |
| Electroporation and Immunotherapy in Metastatic Colorectal Cancer (NCT05609656) | Ismail Gögenur | 2023-01-26 |
| Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... (NCT05470491) | National Cancer Institute (NCI) | 2023-01-26 |
| A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT (NCT05349643) | AmMax Bio, Inc. | 2023-01-26 |
| A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers (NCT05626803) | Vaxart | 2023-01-26 |
| A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma (NCT05551936) | Vaishalee Kenkre | 2023-01-26 |
| Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response (NCT05691959) | Ascension Health | 2023-01-26 |
| Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma (NCT05455697) | University of Washington | 2023-01-26 |
| Efficacy of CTM for Tennis ELbow (NCT06171555) | Indiana Hand to Shoulder Center | 2023-01-26 |
| Cannabidiol as a Treatment for Social Anxiety Disorder (R61) (NCT05571592) | NYU Langone Health | 2023-01-26 |
| Study to Assess SLN124 in Patients With Polycythemia Vera (NCT05499013) | Silence Therapeutics plc | 2023-01-26 |
| Co-administration of CART22-65s and huCART19 for B-ALL (NCT05674175) | Stephan Grupp MD PhD | 2023-01-25 |
| METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia (NCT05109169) | Imperial College London | 2023-01-25 |
| An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer (NCT05500092) | Montefiore Medical Center | 2023-01-25 |
| VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease (NCT05688852) | Ventyx Biosciences, Inc | 2023-01-25 |
| Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer (NCT05528133) | H. Lee Moffitt Cancer Center and Research Institute | 2023-01-25 |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults (NCT05703607) | Pfizer | 2023-01-25 |
| Statins for the Treatment of NASH (NCT04679376) | Mayo Clinic | 2023-01-25 |
| Improving Mental Health Among the LGBTQ+ Community (NCT05540067) | Brown University | 2023-01-25 |
| Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients (NCT05529069) | M.D. Anderson Cancer Center | 2023-01-25 |
| Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma (NCT05465954) | Mayo Clinic | 2023-01-24 |
| Use of Platelet Rich Plasma from Cord Blood Vs Placebo in the Treatment of Vulvar Lichen Sclerosus (NCT06661382) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2023-01-24 |
| Vitamin D to ENhance TraUma REcovery (NCT05458024) | University of North Carolina, Chapel Hill | 2023-01-24 |
| Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation (NCT05684172) | The First Affiliated Hospital of University of Science and Technology of China | 2023-01-24 |
| Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC (NCT05691829) | NYU Langone Health | 2023-01-24 |
| Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer (NCT05563220) | Stemline Therapeutics, Inc. | 2023-01-24 |
| Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy (NCT05187429) | University of Melbourne | 2023-01-24 |
| Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients (NCT05693597) | German University in Cairo | 2023-01-24 |
| N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease (NCT05589766) | Haukeland University Hospital | 2023-01-23 |
| Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors (NCT05642949) | Minghui Pharmaceutical Pty Ltd | 2023-01-23 |
| A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients (NCT06025110) | ITB-Med LLC | 2023-01-23 |
| Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer (NCT05694936) | Australasian Gastro-Intestinal Trials Group | 2023-01-23 |
| A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma (NCT05590377) | Teva Branded Pharmaceutical Products R&D LLC | 2023-01-23 |
| Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma (NCT05256641) | Jonsson Comprehensive Cancer Center | 2023-01-23 |
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance (NCT05470504) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-01-23 |
| A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis (NCT05539963) | Biocomposites Ltd | 2023-01-23 |
| Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors (NCT05652855) | Minghui Pharmaceutical Pty Ltd | 2023-01-23 |
| A Second Trial of the Abbreviated Protocol Two-Stage Exchange (NCT05607030) | Osteal Therapeutics, Inc. | 2023-01-23 |
| A Prospective, One-arm and Open Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia (NCT05694767) | Institute of Hematology & Blood Diseases Hospital, China | 2023-01-22 |
| Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis (NCT05006430) | Prasun Kumar Jalal | 2023-01-21 |
| Impact of Probiotic Supplementation on Cognition and Related Health Outcomes Among Video Gamers (NCT05545813) | Lallemand Health Solutions | 2023-01-21 |
| Metformin as Added on Therapy in Patients With Ulcerative Colitis (NCT05574387) | Tanta University | 2023-01-20 |
| DEgenerative ROtator Cuff Disease and Botulinum TOXin (NCT05327972) | Assistance Publique - Hôpitaux de Paris | 2023-01-20 |
| Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk (NCT05672537) | Tianjin Medical University Cancer Institute and Hospital | 2023-01-20 |
| Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia (NCT05232227) | University of California, San Francisco | 2023-01-20 |
| Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC (NCT05888402) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-01-20 |
| Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries (NCT05674565) | Zagazig University | 2023-01-20 |
| Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke (NCT05240560) | Bioprojet | 2023-01-20 |
| Cerclage and Progesterone for Twin Pregnancies (NCT07319715) | Benha University | 2023-01-20 |
| hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) (NCT05052957) | Leland Metheny | 2023-01-20 |
| Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers (NCT05722288) | City of Hope Medical Center | 2023-01-20 |
| A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis (NCT05757856) | NexEos Diagnostics, Inc. | 2023-01-20 |
| The AXIS Study: the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis (NCT06114537) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-01-20 |
| Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors (NCT05693844) | Chinese PLA General Hospital | 2023-01-20 |
| Assessment of the Efficacy of Letrozole in the Treatment of Ectopic Pregnancy (NCT05918718) | Tehran University of Medical Sciences | 2023-01-20 |
| Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD) (NCT05652907) | Quantum Biopharma | 2023-01-19 |
| An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer (NCT05558904) | Jonsson Comprehensive Cancer Center | 2023-01-19 |
| Testing Obeticholic Acid for Familial Adenomatous Polyposis (NCT05223036) | National Cancer Institute (NCI) | 2023-01-19 |
| Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) (NCT05587712) | Merck Sharp & Dohme LLC | 2023-01-19 |
| A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab (NCT05199285) | Academic and Community Cancer Research United | 2023-01-19 |
| Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21 (NCT05452902) | University of Maryland, Baltimore | 2023-01-19 |
| Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions (NCT06313801) | Nizhny Novgorod Regional Clinical Oncology Center | 2023-01-19 |
| The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis (NCT05772520) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2023-01-19 |
| Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults (NCT05605470) | Technovalia, Pty Ltd | 2023-01-19 |
| Study of M5049 in DM and PM Participants (NEPTUNIA) (NCT05650567) | EMD Serono Research & Development Institute, Inc. | 2023-01-19 |
| A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection (NCT05732454) | Pfizer | 2023-01-18 |
| TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) (NCT05955391) | Shenzhen TargetRx Co., Ltd. | 2023-01-18 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (NCT05556343) | Bristol-Myers Squibb | 2023-01-18 |
| COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide (NCT05434689) | University of Alabama at Birmingham | 2023-01-18 |
| A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19 (NCT05713318) | Huahui Health | 2023-01-18 |
| A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy (NCT05405361) | argenx | 2023-01-18 |
| Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata (NCT05398809) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-01-18 |
| 18F-DCFPyL PET/CT in Hepatocellular Carcinoma (NCT05009979) | National Cancer Institute (NCI) | 2023-01-18 |
| Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases (NCT05647512) | LaNova Medicines Limited | 2023-01-18 |
| Long-term Safety of BCX9930 in Participants With Paroxysmal Nocturnal Hemoglobinuria (NCT05741346) | BioCryst Pharmaceuticals | 2023-01-18 |
| Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus (NCT05669599) | Amgen | 2023-01-18 |
| A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma (NCT05749042) | Xin-Hua Xu | 2023-01-18 |
| Evaluating the Effects of an Oral Protein Supplement on Children's Growth Patterns (NCT06329388) | TruHeight Vitamins | 2023-01-18 |
| Using Of Chitosan in Alveolar Ridge Preservation (NCT06140277) | Prince Sattam Bin Abdulaziz University | 2023-01-18 |
| Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma (NCT05842707) | Aibin Liang，MD，Ph.D. | 2023-01-18 |
| Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI (NCT05480995) | University of North Carolina, Chapel Hill | 2023-01-17 |
| Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms (NCT05656248) | St. Jude Children's Research Hospital | 2023-01-17 |
| [68Ga]Ga-PentixaFor PET/CT in Acute Myocardial Inflammation (NCT05499637) | John O. Prior | 2023-01-17 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) (NCT04803006) | ITB-Med LLC | 2023-01-17 |
| A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma (NCT05593250) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-01-17 |
| Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis (NCT05739435) | Alumis Inc | 2023-01-17 |
| Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms (NCT05709171) | Rigshospitalet, Denmark | 2023-01-17 |
| SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors (NCT05642780) | Klus Pharma Inc. | 2023-01-17 |
| To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation (NCT05541822) | Abion Inc | 2023-01-17 |
| Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC (NCT05720260) | National Taiwan University Hospital | 2023-01-17 |
| Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT05702229) | AstraZeneca | 2023-01-16 |